Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Global Blood Therapeutics amends IPO

    Global Blood Therapeutics Inc., South San Francisco, Calif. Business: Hematology Date announced: 2015-07-31 Type: IPO To be raised: Up to $108 million Shares: 6 million Price: $16-$18 Underwriters: Morgan Stanley; …

    Published on 8/10/2015
  • Abeona Therapeutics completes direct public offering

    Abeona Therapeutics Inc. (NASDAQ:ABEO), Dallas, Texas Business: Gene/Cell therapy, Cancer, Endocrine/Metabolic Date completed: 2015-08-03 Type: Direct public offering Raised: $15.6 million Shares: 2.8 million Price: $5.…

    Published on 8/10/2015
  • Aimmune Therapeutics completes IPO

    Aimmune Therapeutics Inc. (NASDAQ:AIMT), Brisbane, Calif. Business: Inflammation Date completed: 2015-08-06 Type: IPO Raised: $160 million Shares: 10 million Price: $16 Shares after offering: 40.7 million Underwriters: …

    Published on 8/10/2015
  • Antiva Biosciences completes venture financing

    Antiva Biosciences Inc., San Diego, Calif. Business: Infectious Date completed: 2015-08-06 Type: Venture financing Raised: $16 million Investors: Canaan Partners; Sofinnova Ventures; existing investors

    Published on 8/10/2015
  • Avitide completes venture financing

    Avitide Inc., Lebanon, N.H. Business: Biomanufacturing Date completed: 2015-08-06 Type: Venture financing Raised: $7.6 million Investors: NeoMed; Polaris Partners; OrbiMed Advisors; SV Life Sciences; Borealis Ventures; …

    Published on 8/10/2015
  • Celgene completes private placement of senior notes

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Biopharmaceuticals Date completed: 2015-08-04 Type: Private placement of senior notes Raised: $8 billion Underwriters: JPMorgan; BofA Merrill Lynch; Citigroup; …

    Published on 8/10/2015
  • Cold Genesys completes venture financing

    Cold Genesys Inc., Irvine, Calif. Business: Cancer Date completed: 2015-08-05 Type: Venture financing Raised: $10 million Investors: Ally Bridge Group; WI Harper; Whitesun Healthcare Ventures; Song Hong Fang

    Published on 8/10/2015
  • Corium completes follow-on

    Corium International Inc. (NASDAQ:CORI), Menlo Park, Calif. Business: Drug delivery Date completed: 2015-08-05 Type: Follow-on Raised: $52 million Shares: 4 million Price: $13 Shares after offering: 22.2 million …

    Published on 8/10/2015
  • Critical Outcome Technologies completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2015-08-04 Type: Private placement of units Raised: C$836,560 ($636,622) Units: 2.8 …

    Published on 8/10/2015
  • Dermira completes follow-on

    Dermira Inc. (NASDAQ:DERM), Menlo Park, Calif. Business: Dermatology Date completed: 2015-08-05 Type: Follow-on Raised: $96.8 million Shares: 4.5 million Price: $21.50 Shares after offering: 29.2 million Underwriters: …

    Published on 8/10/2015
  • Flexion Therapeutics completes debt financing

    Flexion Therapeutics Inc. (NASDAQ:FLXN), Burlington, Mass. Business: Musculoskeletal, Autoimmune Date completed: 2015-08-04 Type: Debt financing Raised: $15 million Investors: MidCap Financial; Silicon Valley Bank Note:…

    Published on 8/10/2015
  • Intec completes follow-on

    Intec Pharma Ltd. (Tel Aviv:INTP; NASDAQ:NTEC), Jerusalem, Israel Business: Drug delivery Date completed: 2015-08-04 Type: Follow-on Raised: $30.2 million Shares: 5 million Price: $6 Shares after offering: 10.6 million …

    Published on 8/10/2015
  • Marina Biotech completes private placement of convertible preferred stock

    Marina Biotech Inc. (Pink:MRNA), Bothell, Wash. Business: Cancer, Endocrine/Metabolic Date completed: 2015-08-06 Type: Private placement of convertible preferred stock Raised: $1.1 million Shares outstanding prior: 25.6…

    Published on 8/10/2015
  • Metacrine completes venture financing

    Metacrine Inc., San Diego, Calif. Business: Endocrine/Metabolic, Hepatic Date completed: 2015-08-05 Type: Venture financing Raised: $36 million Investors: Arch Venture Partners; EcoR1 Capital; Polaris Partners; venBio …

    Published on 8/10/2015
  • MetaStat completes debt financing

    MetaStat Inc. (OTCQB:MTST), The Woodlands, Texas Business: Diagnostic Date completed: 2015-08-05 Type: Debt financing Raised: $1.2 million Investor: Dolphin Offshore Partners LP Note: The promissory note bears 8% …

    Published on 8/10/2015
  • ProMIS Neurosciences completes private placement

    ProMIS Neurosciences Inc. (TSX:PMN), Mississauga, Ontario Business: Neurology, Cancer, Diagnostic Date completed: 2015-08-04 Type: Private placement Raised: C$998,678 ($759,994) Shares: 33.3 million Price: C$0.03 Shares…

    Published on 8/10/2015
  • Provista Diagnostics completes venture financing

    Provista Diagnostics Inc., New York, N.Y. Business: Diagnostic Date completed: 2015-08-04 Type: Venture financing Raised: $6 million Investor: Existing investors Note: The financing is a series A-2 round.

    Published on 8/10/2015
  • Santhera completes private placement

    Santhera Pharmaceuticals Holding AG (SIX:SANN), Liestal, Switzerland Business: Neurology, Endocrine/Metabolic, Musculoskeletal Date completed: 2015-08-07 Type: Private placement Raised: CHF27.7 million ($28.6 million) …

    Published on 8/10/2015
  • Zynerba completes IPO

    Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE), Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date completed: 2015-08-04 Type: IPO Raised: $42 million Shares: 3 million Price: $14 Shares after offering: 8.7 …

    Published on 8/10/2015
  • AMAG Pharmaceuticals financial update

    AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Lexington, Mass. Business: Hematology Date announced: 2015-08-05 Note: AMAG raised $30.1 million through the sale of 472,500 shares at $63.75 to cover the overallotment from its …

    Published on 8/10/2015
  • Cara Therapeutics financial update

    Cara Therapeutics Inc. (NASDAQ:CARA), Shelton, Conn. Business: Neurology, Inflammation, Dermatology Date announced: 2015-08-04 Note: Cara raised $10.5 million through the sale of 564,516 shares at $18.60 to cover the …

    Published on 8/10/2015
  • Egalet financial update

    Egalet Corp. (NASDAQ:EGLT), Wayne, Pa. Business: Neurology, Cardiovascular, Drug delivery Date announced: 2015-07-31 Note: Egalet raised $11.3 million through the sale of 1 million shares at $11.25 to cover the …

    Published on 8/10/2015
  • NantKwest financial update

    NantKwest Inc. (NASDAQ:NK), Cardiff-by-the-Sea, Calif. Business: Cancer, Inflammation Date announced: 2015-07-31 Note: NantKwest raised $31.1 million through the sale of 1.2 million shares at $25 to cover the …

    Published on 8/10/2015
  • Soligenix financial update

    Soligenix Inc. (OTCBB:SNGX), Princeton, N.J. Business: Transplant, Gastrointestinal, Cancer Date announced: 2015-07-31 Note: Soligenix entered into a $10 million equity purchase agreement with Kodiak Capital Group; …

    Published on 8/10/2015
  • Teva financial update

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date announced: 2015-07-31 Note: Teva secured up to $27 billion in loans under a senior unsecured bridge …

    Published on 8/10/2015

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993